Does hormone replacement therapy (HRT) after risk-reducing salpingo-oophorectomy (RRSO) influence breast cancer risk of non-diseased BRCA1/2-pV carriers or carriers of pV in genes of Lynch syndrome? The gene discussed is BRCA1; the disease is breast cancer.